XOMA Corp. preclinical data

XOMA (Berkeley, Calif.) reported that it has identified a class of fungicidal peptides that appear to act by a mechanism different than currently used antifungal drugs. The peptides show activity against fungi resistant to currently available compounds, and enhance at least one available fungicidal drug. ...